Eve & Co Receives Licence Amendment to Sell Cannabis Extracts, Edibles and Topicals
STRATHROY, Ontario, July 20, 2020 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-C: EVE; […]
Denbury Resources Responds to Fraudulent Press Release
PLANO, Texas, July 20, 2020 (GLOBE NEWSWIRE) — Denbury Resources Inc. (NYSE: DNR) (“Denbury” or the “Company”) today confirmed that […]
Expert 2020 Impacted More Than Five Million People
SÃO PAULO, Brazil, July 20, 2020 (GLOBE NEWSWIRE) — During the last ten years XP Inc. (Nasdaq: XP), a leading, […]
Daxor Corporation Announces Pricing of $7.0 Million Registered Direct Offering
NEW YORK, July 20, 2020 (GLOBE NEWSWIRE) — Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with […]
TILT Holdings Announces New Senior Vice President, Head of Capital Markets and Investor Relations
CAMBRIDGE, Mass., July 20, 2020 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQB: TLLTF), a […]
Bottomline Named a Major Player in Enterprise Fraud Management in Banking by IDC MarketScape
PORTSMOUTH, N.H., July 20, 2020 (GLOBE NEWSWIRE) — Bottomline (NASDAQ: EPAY), a leading provider of financial technology that makes complex […]
Star Bulk Announces Dates for the Release of Second Quarter and Half Year 2020 Results, and Investor Conference Call
ATHENS, Greece, July 20, 2020 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq: SBLK, Oslo: […]
Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 31, 2020
NEW HAMPTON, N.Y., July 20, 2020 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will […]
Borqs Technologies receives increased orders in the COVID-19 pandemic for its mobile personal safety and tracking device for senior citizens; Forecasts to deliver a quarter million units in 2020
SANTA CLARA, Calif., July 20, 2020 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS), (the “Company”, or “Borqs”), a global […]
Arcutis Enrolls Last Patient in Phase 2b Clinical Trial Evaluating ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Scalp Psoriasis
Roflumilast foam potential “Best in Class” topical PDE4 inhibitor in foam formulationScalp psoriasis affects more than 2.5 million U.S. patientsPhase […]
